IBB vs. FBT
IBB (iShares Nasdaq Biotechnology ETF) and FBT (First Trust Amex Biotechnology Index) are both Health & Biotech Equities funds - IBB tracks the NASDAQ Biotechnology Index while FBT tracks the NYSE Arca Biotechnology Index. Both are passively managed. Over the past 10 years, IBB returned 8.21%/yr vs 10.49%/yr for FBT. Their correlation of 0.92 suggests significant overlap in exposure. IBB charges 0.47%/yr vs 0.57%/yr for FBT.
Performance
IBB vs. FBT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IBB achieves a 5.61% return, which is significantly lower than FBT's 11.66% return. Over the past 10 years, IBB has underperformed FBT with an annualized return of 8.21%, while FBT has yielded a comparatively higher 10.49% annualized return.
IBB
- 1D
- 0.62%
- 1M
- 5.52%
- YTD
- 5.61%
- 6M
- 3.57%
- 1Y
- 42.90%
- 3Y*
- 11.80%
- 5Y*
- 2.21%
- 10Y*
- 8.21%
FBT
- 1D
- 0.35%
- 1M
- 8.29%
- YTD
- 11.66%
- 6M
- 7.46%
- 1Y
- 45.08%
- 3Y*
- 13.91%
- 5Y*
- 6.27%
- 10Y*
- 10.49%
IBB vs. FBT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IBB iShares Nasdaq Biotechnology ETF | 5.61% | 27.98% | -2.41% | 3.76% | -13.69% | 0.95% | 26.01% | 25.42% | -9.53% | 21.08% |
FBT First Trust Amex Biotechnology Index | 11.66% | 24.25% | 5.88% | 2.55% | -4.83% | -2.26% | 12.96% | 19.74% | -0.30% | 37.07% |
Correlation
The correlation between IBB and FBT is 0.91, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.91 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.92 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.93 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.93 |
Correlation (All Time) Calculated using the full available price history since Jun 23, 2006 | 0.92 |
The correlation between IBB and FBT has been stable across timeframes, ranging from 0.91 to 0.93 - a consistent structural relationship.
IBB vs. FBT - Sectors Allocation Comparison
Sectors
IBB
FBT
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
IBB
FBT
Basic Materials
IBB
-
FBT
-
Communication Services
IBB
-
FBT
-
Consumer Cyclical
IBB
-
FBT
-
Consumer Defensive
IBB
-
FBT
-
Energy
IBB
-
FBT
-
Financial Services
IBB
-
FBT
-
Industrials
IBB
-
FBT
-
Real Estate
IBB
-
FBT
-
Technology
IBB
-
FBT
-
Utilities
IBB
-
FBT
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IBB vs. FBT — Risk / Return Rank
IBB
FBT
IBB vs. FBT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq Biotechnology ETF (IBB) and First Trust Amex Biotechnology Index (FBT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IBB | FBT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.04 | ||
| Sortino ratioReturn per unit of downside risk | -0.11 | ||
| Omega ratioGain probability vs. loss probability | 1.35 | 1.37 | -0.02 |
| Calmar ratioReturn relative to maximum drawdown | 4.47 | 3.18 | +1.30 |
| Martin ratioReturn relative to average drawdown | 13.77 | 9.39 | +4.38 |
Loading charts...
Drawdowns
IBB vs. FBT - Drawdown Comparison
The maximum IBB drawdown since its inception was -62.85%, which is greater than FBT's maximum drawdown of -40.51%. Use the drawdown chart below to compare losses from any high point for IBB and FBT.
Loading charts...
Drawdown Indicators
| IBB | FBT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -62.85% | -40.51% | -22.34% |
Max Drawdown (1Y)Largest decline over 1 year | -9.63% | -14.26% | +4.63% |
Max Drawdown (3Y)Largest decline over 3 years | -24.85% | -20.05% | -4.80% |
Max Drawdown (5Y)Largest decline over 5 years | -39.82% | -28.98% | -10.84% |
Max Drawdown (10Y)Largest decline over 10 years | -39.82% | -32.37% | -7.45% |
Current DrawdownCurrent decline from peak | 0.00% | 0.00% | 0.00% |
Average DrawdownAverage peak-to-trough decline | -21.14% | -11.14% | -10.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.12% | 4.81% | -1.69% |
Volatility
IBB vs. FBT - Volatility Comparison
iShares Nasdaq Biotechnology ETF (IBB) has a higher volatility of 6.95% compared to First Trust Amex Biotechnology Index (FBT) at 6.54%. This indicates that IBB's price experiences larger fluctuations and is considered to be riskier than FBT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IBB | FBT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.95% | 6.54% | +0.41% |
Volatility (6M)Calculated over the trailing 6-month period | 15.98% | 16.15% | -0.17% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.34% | 21.02% | -0.68% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.03% | 21.88% | +0.15% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.17% | 23.83% | -0.66% |
IBB vs. FBT - Expense Ratio Comparison
IBB has a 0.47% expense ratio, which is lower than FBT's 0.57% expense ratio.
Dividends
IBB vs. FBT - Dividend Comparison
IBB's dividend yield for the trailing twelve months is around 0.23%, while FBT has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBT First Trust Amex Biotechnology Index | 0.00% | 0.00% | 0.71% | 0.00% | 0.00% | 1.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.12% |
IBB iShares Nasdaq Biotechnology ETF | 0.23% | 0.23% | 0.29% | 0.26% | 0.31% | 0.21% | 0.21% | 0.33% | 0.20% | 0.30% | 0.19% | 0.03% |
Frequently Asked Questions
With a correlation of 0.91, IBB and FBT move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.
IBB has higher volatility (6.95%) compared to FBT (6.54%). In terms of maximum drawdown, IBB dropped -62.85% vs FBT's -40.51%.
On 10-year performance, FBT leads with 10.49% vs 8.21% for IBB. On fees, IBB is cheaper at 0.47% per year. On volatility, FBT has been the lower-risk option at 6.54%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, FBT has performed better with a 10.49% return vs 8.21%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IBB is cheaper with a 0.47% expense ratio, compared with 0.57% for FBT.
IBB has the higher dividend yield at 0.23%, compared with 0.00% for FBT.
IBB tracks NASDAQ Biotechnology Index, while FBT tracks NYSE Arca Biotechnology Index. They also come from different issuers: iShares and First Trust. Their fees differ too: 0.47% for IBB and 0.57% for FBT.
FBT currently has the higher Sharpe Ratio (2.16 vs 2.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IBB and FBT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer